Live Analyst Rating Changes 11284 upgrades, downgrades & price-target moves · freshest Wall Street data, updated daily View live feed →
Analyst Tracker/Sean Laaman
MS
Sean Laaman
Morgan Stanley
Wall Street Analyst
★★★★☆
#530
on 13Foresight · ranked by our own returns
65%
Success Rate
+6.6%
Average Return
36 of 55 calls profitable · +0.5% vs benchmark
S&P 500 (SPY)
🔒 3-year track record is Pro. Showing 1-year — upgrade.
📈 Across the calls we could measure, roughly 65% of Sean Laaman's ratings turned a profit when each position was held for 1 year — averaging +6.6% per rating. These figures are computed by 13Foresight from historical prices, not supplied by the analyst.

Rating Distribution

115 Buy 47 Hold 4 Sell
Sean's Stock Coverage 40 ratings · 2026-07-22
Company Date Position Consensus ⓘ Price Target ⓘ 1-Yr Return vs S&P 500 ⓘ
ERAS
Erasca
 Jul 20, 2026 HOLD Strong Buy
+3.3% avg upside
14 analysts
$21.00
8.39% Upside
 +0.0% ·
EXEL
Exelixis
 Jul 06, 2026 HOLD Buy
-24.4% avg upside
34 analysts
$50.00
10.87% Downside
 +1.1% ·
ACAD
ACADIA Pharmaceuticals
 Jun 26, 2026 HOLD Strong Buy
+41.7% avg upside
43 analysts
$26.00
2.27% Upside
 +0.0% ·
ABSI
AbSci
 Jun 25, 2026 HOLD Strong Buy
+45.6% avg upside
18 analysts
$10.00
20.17% Upside
 -18.8% ·
ARGX
Argenx Se
 Jun 24, 2026 BUY Strong Buy
-13.8% avg upside
46 analysts
$1180.00
34.98% Upside
 +0.9% ·
MPLT
MapLight Therapeutics, Inc.
 Jun 22, 2026 BUY Strong Buy
+8.6% avg upside
13 analysts
$34.00
9.27% Downside
 +25.7% ·
IRON
Disc Medicine
 Jun 16, 2026 BUY Strong Buy
+13.2% avg upside
21 analysts
$85.00
12.47% Upside
 +6.5% ·
HALO
Halozyme
 Jun 15, 2026 BUY Strong Buy
-24.7% avg upside
20 analysts
$93.00
18.30% Upside
 +10.3% ·
CGEM
Cullinan Management
 Jun 07, 2026 BUY Strong Buy
+88.0% avg upside
15 analysts
$30.00
66.15% Upside
 +33.2% ·
BBIO
BridgeBio Pharma
 May 27, 2026 BUY Strong Buy
+12.7% avg upside
34 analysts
$98.00
18.95% Upside
 +23.4% ·
DNLI
Denali Therapeutics
 May 26, 2026 BUY Strong Buy
+58.4% avg upside
24 analysts
$35.00
46.89% Upside
 +20.2% ·
BBOT
BridgeBio Oncology Therapeutics
 May 15, 2026 BUY Strong Buy
+188.8% avg upside
10 analysts
$18.00
106.47% Upside
 +0.6% ·
CGON
CG Oncology, Inc.
 May 15, 2026 BUY Strong Buy
+19.8% avg upside
17 analysts
$93.00
29.66% Upside
 +7.2% ·
SDGR
Schrodinger
 May 14, 2026 HOLD Strong Buy
+87.6% avg upside
14 analysts
$17.00
12.56% Upside
 +18.9% ·
GENB
Generate Biomedicines, Inc.
 May 14, 2026 BUY Strong Buy
+76.7% avg upside
6 analysts
$22.00
52.89% Upside
 -11.7% ·
CTNM
Contineum Therapeutics, Inc. Class A
 May 14, 2026 HOLD Strong Buy
+47.3% avg upside
8 analysts
$16.00
15.17% Upside
 -2.2% ·
RXRX
Recursion Pharmaceuticals
 May 14, 2026 HOLD Buy
+158.7% avg upside
12 analysts
$5.50
78.62% Upside
 -0.7% ·
ONC
BeOne Medicines
 May 07, 2026 BUY Strong Buy
+11.1% avg upside
28 analysts
$395.00
24.02% Upside
 -2.0% ·
BMRN
BioMarin Pharmaceutical
 May 06, 2026 BUY Strong Buy
+59.3% avg upside
52 analysts
$119.00
101.01% Upside
 +8.9% ·
NBIX
Neurocrine
 May 06, 2026 HOLD Strong Buy
-0.1% avg upside
37 analysts
$191.00
6.76% Upside
 +16.2% ·
JAZZ
Jazz Pharmaceuticals
 May 05, 2026 BUY Strong Buy
-11.7% avg upside
35 analysts
$245.00
3.59% Downside
 +19.8% ·
AXSM
Axsome Therapeutics
 May 05, 2026 HOLD Strong Buy
-0.9% avg upside
29 analysts
$242.00
2.08% Upside
 +5.8% ·
ALEC
Alector
 May 04, 2026 SELL Buy
+625.7% avg upside
14 analysts
$2.00
29.87% Upside
 +40.2% ·
EIKN
Eikon Therapeutics, Inc.
 Mar 03, 2026 BUY Buy
+139.6% avg upside
5 analysts
$32.00
222.84% Upside
 -27.9% ·
IMCR
Immunocore Holdings
 Feb 26, 2026 HOLD Strong Buy
+86.5% avg upside
22 analysts
$40.00
16.09% Upside
 +7.6% ·
AU:SIG
Sigma Healthcare Ltd
 Aug 28, 2025 BUY Strong Buy
+119.3% avg upside
10 analysts
$3.30
14.22% Upside
 -4.7% ·
CERT
Certara
 Jul 02, 2025 HOLD Buy
+88.8% avg upside
21 analysts
$16.00
133.64% Upside
 -39.3% ·
AU:MPL
Medibank Private
 Feb 12, 2025 HOLD Hold
-13.8% avg upside
2 analysts
$3.95
22.80% Downside
 +17.9% ·
RMD
Resmed
 Aug 01, 2024 HOLD Buy
+17.3% avg upside
27 analysts
 — +31.3% ·
AU:RMD
Resmed Inc CHESS Depositary Interests on a ratio of 10 CDIs per ord.sh
 Jun 24, 2024 BUY Strong Buy
+46.7% avg upside
11 analysts
$33.70
21.52% Upside
 +41.5% ·
AU:CSL
CSL
 Jun 12, 2024 BUY Strong Buy
+50.4% avg upside
15 analysts
$310.00
162.81% Upside
 -15.8% ·
AU:SHL
Sonic Healthcare Limited
 May 22, 2024 BUY Buy
+22.4% avg upside
12 analysts
$31.65
52.07% Upside
 +7.1% ·
AU:ANN
Ansell
 Apr 09, 2024 HOLD Buy
+2.3% avg upside
9 analysts
$24.14
24.61% Downside
 +16.3% ·
AU:COH
Cochlear
Mar 21, 2024 SELL Hold
+52.3% avg upside
15 analysts
$256.00
128.20% Upside
 +16.9% ·
AU:HLS
Healius Limited
 Feb 28, 2024 SELL Sell
+138.1% avg upside
10 analysts
$1.30
266.28% Upside
 -15.8% ·
AU:NHF
NIB Holdings Ltd
 Feb 27, 2024 HOLD Sell
-9.2% avg upside
2 analysts
$7.35
0.48% Downside
 -5.6% ·
AU:MVF
Monash IVF Group Ltd
 Feb 26, 2024 BUY Strong Buy
+44.7% avg upside
7 analysts
$1.65
146.25% Upside
 -12.5% ·
AU:RHC
Ramsay Health Care
 Nov 28, 2023 HOLD Hold
-5.8% avg upside
14 analysts
$51.60
20.68% Upside
 -17.8% ·
AU:IDX
Integral Diagnostics Ltd.
 Aug 28, 2023 SELL Strong Buy
+51.5% avg upside
12 analysts
$2.75
33.40% Upside
 +7.6% ·
SKHHY
Sonic Healthcare
 Aug 24, 2021 BUY Buy
5 analysts
 — -18.6% ·
🔒 35 more ratings — with price targets, crowd consensus and our measured returns.
Sign in free to unlock See Pro plans
Free account unlocks every analyst's full coverage table.
Sean Laaman — Frequently Asked Questions
How accurate are Sean Laaman's stock ratings?
Based on the calls 13Foresight could measure, about 65% of Sean's ratings were profitable over a one-year hold, with an average return of +6.6% per rating, or +0.4% versus the S&P 500. We score every analyst the same way, from historical prices. Each return is measured in the stock's own trading currency, so for non-US listings the S&P 500 comparison leaves out currency moves.
How is Sean ranked on 13Foresight?
Sean Laaman is currently ranked #530 with a 4-star rating. Our rank blends hit rate, average return versus the market, and how many calls we have to judge — so a long, consistent record outweighs a few lucky picks. It is our own calculation, updated daily.
Which stocks does Sean cover?
Sean most recently has ratings on ERAS, EXEL, ACAD, ABSI, ARGX, MPLT, IRON, HALO, CGEM, BBIO, DNLI, BBOT and 28 more. See the full coverage table above for positions, price targets and our measured returns.
Where can I see other analyst ratings?
Browse the full analyst leaderboard to compare Wall Street analysts ranked by their measured performance, success rate and average return.

Disclaimer: 13Foresight compiles analyst ratings and price targets from publicly available sources. Performance metrics, rankings and star ratings shown here are calculated independently by 13Foresight from historical market prices and may differ from figures published elsewhere. This information may be incomplete, delayed or inaccurate, is provided for research and informational purposes only, and is not investment advice. The underlying ratings and opinions are those of the respective analysts and their firms; 13Foresight accepts no liability for any decisions made based on this data.